Publicacions en què col·labora amb Vladimir Rosa Salazar (17)

2023

  1. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

    British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981

2022

  1. Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid Tumors

    Thrombosis and Haemostasis, Vol. 122, Núm. 9, pp. 1594-1602

  2. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

    Viruses, Vol. 14, Núm. 2

2018

  1. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

    American Journal of Medicine, Vol. 131, Núm. 4, pp. 430-437

2017

  1. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

    Journal of Vascular Surgery: Venous and Lymphatic Disorders

  2. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

    Chest, Vol. 151, Núm. 3, pp. 564-571

  3. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

    American Journal of Medicine, Vol. 130, Núm. 4, pp. 482.e1-482.e9

  4. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

    American Journal of Medicine, Vol. 130, Núm. 3, pp. 337-347

2015

  1. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs

    American Journal of Medicine, Vol. 128, Núm. 1, pp. 90.e9-90.e15

  2. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity

    Journal of Thrombosis and Haemostasis, Vol. 13, Núm. 7, pp. 1274-1278

  3. Fondaparinux in the initial and long-term treatment of venous thromboembolism

    Thrombosis Research, Vol. 135, Núm. 2, pp. 311-317

  4. Long-term anticoagulant therapy of patients with venous thromboembolism. What are the practices?

    PLoS ONE, Vol. 10, Núm. 6

2013

  1. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: Data from the RIETE registry

    Respiratory Research, Vol. 14, Núm. 1

2012

  1. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism

    Journal of Thrombosis and Haemostasis, Vol. 10, Núm. 5, pp. 751-759

2011

  1. Effect of the time of diagnosis on outcome in patients with acute venous thromboembolism: Findings from the RIETE registry

    Thrombosis and Haemostasis, Vol. 105, Núm. 1, pp. 45-51

  2. Prevention of venous thromboembolism in patients with cancer in Spain

    Journal of Coagulation Disorders, Vol. 3, Núm. 1, pp. 64-68

2006

  1. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: Findings from the RIETE registry

    Journal of Thrombosis and Haemostasis, Vol. 4, Núm. 9, pp. 1950-1956